YPrime's new TSJC eCOA assessment enables clinical trial professionals to assess disease activity that affects the joints with greater efficiency. TSJC delivers unparalleled speed, accuracy, and ease—improving data quality and accelerating the development of life-changing therapies.
YPrime's new TSJC eCOA assessment enables clinical trial professionals to assess disease activity that affects the joints with greater efficiency. TSJC delivers unparalleled speed, accuracy, and ease—improving data quality and accelerating the development of life-changing therapies.